1 high performance healthcare: mission, strategy, & measurement jonathan b. perlin, md, phd,...

37
1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas J. Hogan Director, Management Support Office OPM Strategic Compensation Conference August, 2001

Post on 20-Dec-2015

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

1

High Performance Healthcare:Mission, Strategy, & Measurement

Jonathan B. Perlin, MD, PhD, MSHA, FACP

Chief Quality and Performance Officer&

Thomas J. Hogan

Director, Management Support Office

Veterans Health Administration

Department of Veterans Affairs

OPM Strategic Compensation ConferenceAugust, 2001

Page 2: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

2

“High Performance Organizations”

HPO’s are outcomes oriented. The desired outcomes are clearly delineated, and the organization actively and continuously assesses its performance based on outcomes. In addition, HPO’s are customer-focused.

Michael Edmond, MD, MPH, ACPE Click;9/2000:www.acpe.org/Click/

Page 3: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

3

. . . Abraham Lincoln

To Care for Him Who Shall To Care for Him Who Shall Have Borne the Battle , and Have Borne the Battle , and for His Widow , and His for His Widow , and His Orphan . . .Orphan . . .

Mission

Page 4: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 4

Mission Assumptions

Effective in serving Veterans health & social needs

Multiple Stakeholders including: Executive & Legislative Branches of Federal

Government Veteran Service Organizations Community (including govt), Healthcare

Community, Business (Academic) Partners Fellow Employees

VHA STRATEGIES

VA DEPARTMENTAL GOALS

VA DEPARTMENTAL OBJECTIVES

VHA GOALS “SIX FOR 2006”

VHA STRATEGIC TARGETS & PERFORMANCE MEASURES

Page 5: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 5

Mission drives strategy

Strategy drives measures

Measures drive change

COSTEFFECTIVENSS

QUALITY

ACCESS

SATISFACTION

HEALTHYCOMMUNITIES

FUNCTIONALSTATUS

Mission Guides Strategy:Strategic Goal Areas

Page 6: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 6

Strategic Realities:Planning Assumptions

Good Management ( and Resource Constraints ) Compel Difficult Questions

Compel Accountability for Performance and VALUE Is VA Care Valuable?

Does VA Provide Quality? Satisfaction? Access? Safety?Is Care Cost-Effective?

• Is there ( Unacceptable ) Variability?

How would we know ( prove ) these things?How do we measure and manage to create and

demonstrate (Health Care) VALUE?

Page 7: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 7

Page 8: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 8

Value = QUALITY

Cost

Challenge: Create ValueFor Veterans and America

Value = OUTCOMES

Cost

Page 9: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 9

Measuring VAlueWhere the Rubber Hits the Road

VHA “Domains-of-Value” = Strategic Goal Areas Quality Access Community Health

Satisfaction Functional Status Cost-Effectiveness

Provide consistently reliable, accessible, satisfying, high-quality care which maximizes functional status, is cost-effective and fosters healthy communities . . .

Challenge: To Create & Communicate VALUE

Value = Access + Technical + Functional + Satisfaction + Community Health

Cost

Page 10: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 10

Variation Also Occurs at the Facility, Clinic & Practitioner Level

after DA Burnett, ©UHC, 1995

Positive Variation

Negative Variation

Page 11: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 11

after DA Burnett, ©UHC, 1995

Reasonable Expectation

Unfortunate Experience

Variation Also Occurs at the Facility, Clinic & Practitioner Level

Page 12: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 12

after DA Burnett, ©UHC, 1995

Justifiable

Unjustifiable

Variation Also Occurs at the Facility, Clinic & Practitioner Level

Page 13: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 13

after DA Burnett, ©UHC, 1995

How do we capture andsystematize best practices?

How do we drive these practicesto be more like those above?

How do we know – throughout VHA –

how we’re doing?

Variation Also Occurs at the Facility, Clinic & Practitioner Level

Page 14: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 14

What’s Wrong With Variation?

Not All Variation is Positive Inconsistent Quality Inconsistent Cost (Efficiency) Inconsistent Access Inconsistent Satisfaction

Inconsistent Outcomes reflect inconsistent processes

Sub-optimal outcomes reflect sub-optimal processes

A.K.A. The Quality Chasm

Page 15: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 15

So, Who is VA, VHA?Veterans Health Administration

Agency of the Department of Veterans Affairs • Veterans Benefits Administration• National Cemetery Administration

Almost 4 million patients, ~ 5 million enrollees ~ 1,300 Sites-of-Care, including > 170 medical

centers or hospitals, > 600 clinics, long-term care, domiciliaries, home-care programs

~ $21 Billion budget (flat at ~ $19B from 1995 - 1999)

180,000 FTEE (~15,000 MD , 30,000 RN) Affiliations with 107 Academic Health Systems

60% US health professionals with some training in VASeparate $1B Research Budget; focus on human DZ / HSR

Page 16: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 16

A “New VA?”… Back to the Data

Page 17: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 17

Vaccine Cuts Pneumonia Risk in High-Risk PatientsArchives of Internal Medicine 1999;159:2437-2442Dr. Kristin Nichol, VAMC / Minneapolis

50% of elderly Americans / high-risk individuals have not received the pneumococcal vaccine.

VAMC study of 1,900 elderly patients with chronic lung disease; 2/3 vaccinated against pneumonia.

Pneumococcal vaccination: 43% reduction in hospitalizations for pneumonia and influenza, and a

29% reduction in the risk of death.

Pneumonia and Influenza vaccination: 72% reduction in hospitalizations for these two diseases and an 82%

reduction in deaths from all causes.

Pneumococcal vaccination saved an average of $294 per vaccine recipient over the 2-year period.

Page 18: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 18

Pneumococcal Vaccination Rates

0

20

40

60

80

100

FY 95 4th Qtr 97 4th Qtr 98 Cum 99 Cum 00

Pe

rce

nt

Va

cc

ina

ted

VHA Healthy People 2000 Iowa 99*

* Iowa: Petersen, Med Care 1999;37:502-9. >65/ch dz

Page 19: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 19

Extrapolating from Dr. Nichol’s study:

Between 1996 and 1998, Increased Rates of Pneumococcal Vaccination Averted 3914 Excess Deaths Nationally in VA Patients with Chronic Lung Disease . . .

Page 20: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 20

Quality:Influenza Vaccination Rates

0

20

40

60

80

100

FY 95 4th Qtr 97 4th Qtr 98 Cum 99 Cum 00

An

nu

al

Infl

ue

nza

Va

cc

ine

VHA Healthy People 2000 Iowa 99

Page 21: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 21

Quality: Gender / Age Approp CareBreast CA & Cervical CA Screen

0

20

40

60

80

100

FY 95 4th Qtr 97 4th Qtr 98 Cum 99 Cum 00

VHA NCQA Healthy People 2000

0

20

40

60

80

100

FY 95 4th Qtr 97 4th Qtr 98 Cum 99 Cum 00

VHA NCQA Healthy People 2000

Page 22: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 22

Quality:Diabetes Measures

0

15

30

45

60

75

90

1995 1997 1998 1999 2000

A1c

A1c < 9.5

Ft Exam

Ft Sens

Nutrition

Smoking

Ret Exam

Sawin CT, Walder DJ, Bross DS, Pogach LM, “Diabetes process and outcome measures in the VHA,” Diabetes Care, 1999

Age-Standardized Amputation Rates have decreased 12% . . . And may be National Benchmark

Page 23: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 23

Survival after MISoumerai SB "Adverse Outcomes of Underuse of Beta Blockers in Elderly

Survivors of Acute Myocardial Infarction," JAMA 1997; 277(2):115-21

Elderly patients who receive beta blockers following a heart attack are 43 percent less likely to die in the first 2 years following the attack than patients who do not receive this drug, according to a new study funded by the Agency for Health Care Policy and Research (AHCPR), published in the January 8 issue of The Journal of the American Medical Association (JAMA).

The study found that patients who receive beta blockers are rehospitalized for heart ailments 22 percent less often than those who do not get beta blockers. However, only 21 percent of eligible patients receive beta blocker therapy.

Researchers found that these patients were almost three times as likely to receive a new prescription for a calcium channel blocker than for a beta blocker after their AMI. Eligible patients receiving calcium channel blockers instead of beta blockers doubled their risk of death.

Page 24: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 24

Beta Blocker following AMIin VHA Medical Centers

0

20

40

60

80

100

FY 95 4th Qtr 97 4th Qtr 98 Cum 99 Cum 00

Pe

rce

nt

Eli

gib

le P

ati

on

s

VHA NCQA AHCPR (NJ) Non-Govt

AHCPR: Soumerai et al. JAMA 1997;277(2):115-21Non-Govt: Krumholz HM et al. Ann Int Med 1999;131(9):648-54

Improved Provision ofBeta Blockers Has SavedOver 500 Lives since 1996

Page 25: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 25

What others are saying:Teaching Status & Cardiac Care

Allison JJ et al, JAMA 2000;284:1256-1262

ASA b-BLK ACE0

20

40

60

80

100

Per

cent

Elig

ible

Pts

-

AMC

NT

Page 26: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 26Allison JJ et al, JAMA 2000;284:1256-1262

ASA b-BLK ACE0

20

40

60

80

100

Per

cent

Elig

ible

Pts

VA

AMC

NT

What others are saying:Teaching Status & Cardiac Care

Page 27: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 27

NSQIP: National Surgery Quality Improvement Program

Page 28: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 28

Chronic Disease Index:1996 - 1999

Chronic Disease Index

Chronic Obstructive PulmonaryDisease (COPD): Inhaler Use Observation /

Education (Inpatient) Inhaler Use Observation /

Education (Outpatient)Diabetes Mellitus: Annual Pedal Pulse Evaluation Annual Sensory examination of

Feet Annual Visual Foot Inspection Annual Hemoglobin A1c Annual Retinal ExamHypertension: Exercise Counseling Nutrition CounselingIschemic Heart Disease: Aspirin Use post-Myocardial

Infarction Beta-Blocker use post-

Myocardial Infarction Cholesterol Management post-

Myocardial Infarction

0

20

40

60

80

100

1996 1997 1998 1999

Page 29: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 29

Prevention Index

Prevention Index:

Immunization: Influenza Immunization Pnuemococcal VaccinationCancer Screening: Breast Cancer Screening Cervical Cancer Screening Colorectal Cancer Screening Prostate Cancer ScreeningSubstance Use: Alcohol Use Tobacco Use Smoking Cessation Counseling 0

20

40

60

80

100

1996 1997 1998 1999 2000

Page 30: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 30

0

100

200

300

400

500

600

700

800

1995 1997 1998 1999 2000

CB

OC

s (in

clud

ing

faci

lity-

base

d)

0

10000

20000

30000

40000

50000

60000

70000

80000

90000

100000

Be

ds

Access: GeographicSupporting Better Primary Care

20

25

30

35

40

45

199419951996199719981999

Ou

tpt

Vis

its

(M

illio

ns

)

400000

500000

600000

700000

800000

900000

1000000

Inp

t Ad

mits

Page 31: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 31

Percent Patients Seen in 20 Minutes

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

VI S

NV

I SN

Nat

l

VISN & National Performance

0

20

40

60

80

100P

erce

nt W

ait

Less

Tha

n 20

Mi n

utes

YEAR1995

1996

1997

1998

1999

2000

2000.2

Page 32: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 32

Satisfaction:Progress & Opportunity …

2000: 79 of 100 on external American Customer Satisfaction Index (Univ. of Michigan) Outpt Care

2001: 82/100 Inpatient & 83/100 PharmacySignificantly better than private health sector average of 68

• Loyalty Score of 90 and Customer Service Score of 87 were healthcare benchmarks!

National VA data: Opportunity for improvement Priority Areas Identified: Access, Coordination of Care, Health

Information, Pain Management

Page 33: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 33

A New VA: New Strategies… Outcomes Don’t Just Happen

Outcomes Can & Should Be Specified Linking Mission & Vision with Measurement &

Management of Outcomes Identify Variability

Assess opportunity ( negative variation )• Risk (“delta” between current and ideal) – “IOM Quality Chasm”

– Prioritize (e.g. volume, other significant factors)

Identify and Implement “Best Practices”Spectrum of Outcomes, Spectrum of Measures

• Measures provide “Tension” - Accountability for Outcomes

Page 34: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 34

Challenge: Identify Needs, Set Direction, Measure Performance & Articulate Outcomes

Kaplan & NortonConcept of

balanced perspective

Link of Goals with Measures

Real World: Perspectives don’t operate in isolation

Page 35: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 35

Not Necessarily Pretty, But Pretty Effective

VALUES, GOALS, STRATEGIES

Performance Measures

Page 36: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 36

Changing the Paradigm:From HR to Management Support

________________Thomas J. Hogan

Director, Management SupportVeterans Health Administration

Page 37: 1 High Performance Healthcare: Mission, Strategy, & Measurement Jonathan B. Perlin, MD, PhD, MSHA, FACP Chief Quality and Performance Officer & Thomas

VHA Office of Quality & Performance: May, 2001 37

When You Think VA,Think VAlue for Veterans

IMPROVING ACCESS

BENCHMARK OUTCOMES in

• PREVENTIVE HEALTH

• DISEASE TREATMENT

• CUSTOMER SATISFACTION

LEADING PATIENT SAFETY